|
Volumn 11, Issue 4, 2002, Pages 341-342
|
Response to ISPE commentary
a
a
HEALTH CANADA
(Canada)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NEW DRUG;
ARTICLE;
CANADA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
HEALTH CARE FINANCING;
HEALTH CARE ORGANIZATION;
HEALTH CARE POLICY;
HUMAN;
MEDICAL DECISION MAKING;
POSTMARKETING SURVEILLANCE;
PRIORITY JOURNAL;
TIME;
UNITED STATES;
|
EID: 0036299480
PISSN: 10538569
EISSN: None
Source Type: Journal
DOI: 10.1002/pds.741 Document Type: Article |
Times cited : (2)
|
References (2)
|